MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
103 M |
Market Cap[1] |
$ 249 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Sigilon Therapeutics
SGTX
|
- | - | $ 728 M | Nasdaq Global Select Market | USA |
 |
Rubius Therapeutics
RUBY
|
- | -33.55 % | $ 7.81 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
TRACON Pharmaceuticals
TCON
|
- | -1.38 % | $ 46.8 M | Nasdaq Capital Market | USA |
 |
Edesa Biotech
EDSA
|
$ 2.56 | -7.58 % | $ 14.5 M | Nasdaq Capital Market | USA |
 |
Greenwich LifeSciences
GLSI
|
$ 17.42 | 8.67 % | $ 236 M | Nasdaq Capital Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Revance Therapeutics
RVNC
|
- | - | $ 309 M | Nasdaq Global Select Market | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Forward Pharma A/S
FWP
|
- | -0.75 % | $ 18.7 M | Nasdaq Capital Market |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Nabriva Therapeutics plc
NBRV
|
- | - | $ 4.55 M | Nasdaq Global Select Market |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
NGM Biopharmaceuticals
NGM
|
- | - | $ 127 M | Nasdaq Global Select Market,SPB | USA |
 |
Regulus Therapeutics
RGLS
|
- | - | $ 155 M | Nasdaq Global Select Market | USA |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |
 |
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | USA |
 |
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | USA |
 |
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | USA |
 |
Gamida Cell Ltd.
GMDA
|
- | -18.25 % | $ 5.04 M | Nasdaq Global Market |  Israel |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.45 | 13.31 % | $ 4.98 M | Nasdaq Capital Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 39.12 | 0.17 % | $ 174 B | NYSE | Danmark |
 |
Abeona Therapeutics
ABEO
|
$ 4.33 | -1.7 % | $ 229 M | Nasdaq Capital Market | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.16 | 3.97 % | $ 259 K | NYSE American | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.63 | 11.85 % | $ 162 M | Nasdaq Global Market | USA |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.64 | -2.15 % | $ 38.4 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 228.15 | 1.84 % | $ 29.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.04 | -3.77 % | $ 180 M | Nasdaq Global Market | USA |
 |
Assembly Biosciences
ASMB
|
$ 19.65 | -0.96 % | $ 220 M | Nasdaq Global Select Market,SPB | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 245.48 | 0.87 % | $ 14.9 B | Nasdaq Global Select Market | Danmark |
 |
Beam Therapeutics
BEAM
|
$ 23.79 | -1.08 % | $ 2.35 B | Nasdaq Global Select Market | USA |
 |
Benitec Biopharma
BNTC
|
$ 8.58 | -0.81 % | $ 399 M | Nasdaq Capital Market | USA |
 |
Capricor Therapeutics
CAPR
|
$ 5.72 | -3.54 % | $ 266 M | Nasdaq Capital Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.37 | 1.5 % | $ 452 M | Nasdaq Global Market | USA |
 |
Cullinan Management
CGEM
|
$ 14.55 | 1.25 % | $ 877 M | Nasdaq Global Select Market | USA |
 |
Curis
CRIS
|
$ 0.38 | -2.33 % | $ 5 M | Nasdaq Global Market | USA |
 |
CorMedix
CRMD
|
$ 7.95 | 1.27 % | $ 573 K | Nasdaq Global Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 14.37 | 3.53 % | $ 929 M | NYSE | USA |
 |
NuCana plc
NCNA
|
$ 1.03 | 4.54 % | $ 11.6 B | Nasdaq Global Select Market | Britain |
 |
BioVie
BIVI
|
$ 1.33 | 7.26 % | $ 1.96 M | Nasdaq Capital Market | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.6 | -1.84 % | $ 12.8 M | NYSE American,SPB | USA |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.15 | -9.84 % | $ 60.4 M | Nasdaq Global Select Market | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 60.7 | -0.87 % | $ 7.29 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.